Clinical Trials Directory

Trials / Sponsors / Eyetech Pharmaceuticals

Eyetech Pharmaceuticals

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
UnknownA Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subje
Age-Related Macular Degeneration (AMD)
Phase 42006-06-01
TerminatedA Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients
Macular Degeneration
Phase 42006-04-01
TerminatedMacugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne
Age-Related Macular Degeneration
Phase 42005-03-01
CompletedIntravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Macular Degeneration
N/A2004-07-01
CompletedPegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondar
Retinal Vein Occlusion
Phase 22004-05-01
CompletedPegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (
Macular Degeneration
Phase 22004-03-01
CompletedStudy of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients
Age-Related Macular Degeneration
Phase 2 / Phase 32002-11-01
CompletedPegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
Diabetic Macular Edema
Phase 22002-10-01
CompletedPhase II/III Study of Anti-VEGF in Neovascular AMD
Macular Degeneration, Choroidal Neovascularization
Phase 2 / Phase 32001-07-01
CompletedA Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in
Age-Related Macular Degeneration
Phase 2 / Phase 32001-05-01